Study designs for evaluating different efficacy and effectiveness aspects of vaccines

American Journal of Epidemiology

Volumn 146, Issue 10, 1997, Pages 789-803

  Elizabeth Halloran, M ^a   Struchiner, Claudio J ^a   Longini Jr , Ira M ^b  

^a EMORY UNIVERSITY   (United States)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

Clinical trials; Communicable diseases; Community trials; Vaccine efficacy; Vaccines

Indexed keywords

VACCINE;

CALCULATION; DISEASE COURSE; DISEASE PREDISPOSITION; DISEASE TRANSMISSION; DRUG EFFICACY; HEALTH PROGRAM; INFECTION; REVIEW; VACCINATION;

EID: 0030723556     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.aje.a009196     Document Type: Review

References (36)

1. Greenland S, Robins JM. Conceptual problems in the definition and interpretation of attributable fractions. Am J Epidemiol 1988;128:1185-97.
2. Robins JM, Greenland S. Estimability and estimation of excess and etiologic fractions. Stat Med 1989;8:845-59.
3. Ross R. An application of the theory of probabilities to the study of a priori pathometry. Part 1. Proc R Soc Ser A 1916;92:204-30.
4. Halloran ME, Struchiner CJ. Causal inference in infectious diseases. Epidemiology 1995;6:142-51.
5. Struchiner CJ, Halloran ME, Robins JM, et al. The behaviour of common measures of association used to assess a vaccination programme under complex disease transmission patterns-a computer simulation study of malaria vaccines. Int J Epidemiol 1990;19:187-96.
6. Halloran ME, Struchiner CJ. Study designs for dependent happenings. Epidemiology 1991;2:331-8.
7. Halloran ME, Longini IM Jr, Haber M, et al. Exposure efficacy and change in contact rates in evaluating prophylactic HIV vaccines in the field. Stat Med 1994;13:357-77.
8. Greenwood M, Yule UG. The statistics of anti-typhoid and anti-cholera inoculations, and the interpretation of such statistics in general. Proc R Soc Med 1915;8(part 2):113-94.
9. Fox JP, Hall CE, Elveback LR. Epidemiology: man and disease. New York, NY: MacMillan Publishing Company, Inc, 1970.
10. Orenstein WA, Dernier RH, Dondero TJ, et al. Field evaluation of vaccine efficacy. Bull World Health Organ 1985;63: 1055-68.
11. Orenstein WA, Bemier RH, Hinman AR. Assessing vaccine efficacy in the field: further observations. Epidemiol Rev 1988;10:212-41.
12. Fine PE, Clarkson JA, Miller E. The efficacy of pertussis vaccines under conditions of household exposure: further analysis of the 1978-80 PHLS/ERL study in 21 area health authorities in England. Int J Epidemiol 1988;17:635-42.
13. Kendrick P, Eidering G. A study in active immunization against pertussis. Am J Hyg Sect B 1939;38:133.
14. Rhodes PH, Halloran ME, Longini IM Jr. Counting process models for differentiating exposure to infection and susceptibility. J R Stat Soc B 1996;58:751-62.
15. Cox DR. Regression models and life tables (with discussion). J R Stat Soc (B) 1972;34:187-220.
16. Halloran ME, Haber M, Longini IM Jr, et al. Direct and indirect effects in vaccine field efficacy and effectiveness. Am J Epidemiol 1991; 133:323-31.
17. Smith PG, Rodrigues LC, Fine PE. Assessment of the protective efficacy of vaccines against common diseases using casecontrol and cohort studies. Int J Epidemiol 1984;13:87-93.
18. Halloran ME, Haber M, Longini IM Jr. Interpretation and estimation of vaccine efficacy under heterogeneity. Am J Epidemiol 1992;136:328-43.
19. Longini IM Jr, Halloran ME. A frailty mixture model for estimating vaccine efficacy. Appl Stat 1996:45:165-73.
20. Halloran ME, Longini IM Jr, Struchiner CJ. Estimability and interpretation of vaccine efficacy using frailty mixing models. Am J Epidemiol 1996;144:83-97.
21. Struchiner CJ, Halloran ME. Randomization and baseline transmission in vaccine field trials. (Technical report no. 967). Atlanta, GA: Emory University, 1996.
22. Durham LK, Longini IM Jr, Halloran ME, et al. Nonparametric estimation of waning vaccine effects using Schoenfeld residuals from the Cox model. (Technical report no. 97-7). Atlanta, GA: Emory University, 1997.
23. Halloran ME, Struchiner CJ, Spielman A. Modeling malaria vaccines. II. Population effects of stage-specific malaria vaccines dependent on natural boosting. Math Biosci 1989;94: 115-49.
24. Halloran ME, Watelet L, Struchiner CJ. Epidemiologie effects of vaccines with complex direct effects in an age-structured population. Math Biosci 1994;121:193-225.
25. Halloran ME, Cochi SL, Lieu TA, et al. Theoretical epidemiologic and morbidity effects of routine varicella immunization of preschool children in the United States. Am J Epidemiol 1994:140:81-104.
26. Koopman JS, Little RJ. Assessing HIV vaccine effects. Am J Epidemiol 1995;142:I113-20.
27. Longini IM Jr, Datta S, Halloran ME. Measuring vaccine efficacy for both susceptibility to infection and reduction in infectiousness for prophylactic HIV-1 vaccines. J Acquir Immune Defic Syndr Hum Retrovirol 1996:13:440-7.
28. Halloran ME. Evaluating HIV vaccines: discussion. Stat Med 1996;15:2405-12.
29. Longini IM Jr, Sagatelian K, Rida WN, et al. Optimal vaccine trials design when estimating vaccine efficacy for susceptibility and infectiousness from multiple populations. Stat Med (in press).
30. Monto AS, Davenport FM, Napier JA, et al. Effect of vaccination of a school-age population upon the course of an A2-Hong Kong influenza epidemic. Bull World Health Organ 1969:41:537-42.
31. Grosskurth H, Mosha F, Todd J, et al. Impact of improved treatment of sexually transmitted diseases on HIV infection in rural Tanzania: randomised controlled trial. Lancet 1995;346: 530-6.
32. Katz J, Carey VJ, Zeger SL, et al. Estimation of design effects and diarrhea clustering within households and villages. Am J Epidemiol 1993:138:994-1006.
33. Clemens J, Brenner R, Rao M, et al. Evaluating new vaccines for developing countries: efficacy or effectiveness? JAMA 1996:275:390-7.
34. Hayes R, Mosha F, Nicoll A, et al. A community trial of the impact of improved sexually transmitted disease treatment on the HIV epidemic in rural Tanzania. 1. Design. AIDS 1995; 9:919-26.
35. Anderson RM, May RM. Infectious diseases of humans: dynamics and control. New York, NY: Oxford University Press, 1991.
36. Golm GT, Halloran ME, Longini IM Jr. Semiparametric models for mismeasured exposure information in vaccine trials. (Technical report no. 97-5). Atlanta, GA: Emory University, 1997.